Sun Pharmaceutical

Takeda sells non-Colcrys URL Pharma to Sun Pharmaceutical

Tuesday, December 18, 2012 10:13 AM

Takeda Pharmaceuticals U.S.A. has entered into a definitive agreement to sell the non-Colcrys (colchicine, USP) URL Pharma generic business to Caraco Pharmaceutical Laboratories, a wholly-owned subsidiary of Sun Pharmaceutical Industries.

More... »

Sun Pharma to acquire DUSA Pharmaceuticals

Friday, November 9, 2012 12:06 PM

Sun Pharmaceutical, an international, specialty pharmaceutical company based in India, has agreed to acquire DUSA Pharmaceuticals, a Wilmington, Mass.-based dermatology company focused on photodynamic therapy.

More... »

Pfizer, Hisun launch joint venture Hisun-Pfizer Pharmaceuticals

Friday, September 14, 2012 11:13 AM

Pfizer, the world's largest research-based pharmaceutical company, and Zhejiang Hisun Pharmaceuticals, a Chinese pharmaceutical company, have launched their joint venture Hisun-Pfizer Pharmaceuticals, to develop, manufacture and commercialize off-patent pharmaceutical products in China and global markets.

More... »

Sun Pharmaceutical to acquire Taro

Monday, August 13, 2012 09:57 AM

Sun Pharmaceutical Industries, an Indian specialty pharmaceutical company, and Taro Pharmaceutical Industries, a multinational pharmaceutical company, have entered into a merger agreement together with certain affiliates of Sun Pharma.

More... »

Taro rejects Sun Pharma offer

Thursday, July 19, 2012 02:25 PM

The special committee of the board of directors of Taro Pharmaceutical Industries unanimously rejected the Oct. 18, 2011, unsolicited, non-binding offer from Sun Pharmaceutical Industries—to purchase all of the issued and outstanding shares of Taro not currently held by Sun Pharma for $24.50 per share—as inadequate and not in the best interests of Taro's minority shareholders.

More... »

Pfizer and Hisun to increase access to high-quality generics

Wednesday, February 22, 2012 02:00 PM

Pfizer and Zhejiang Hisun Pharmaceutical are establishing a joint venture to develop, manufacture and commercialize off-patent pharmaceutical products in China and global markets.

More... »

Merck and Sun sign pact

Tuesday, April 26, 2011 11:41 AM

Merck and India-based Sun Pharmaceutical Industries have collaborated regarding rights to Merck’s diabetes drug Januvia, according to Pharma Times.

More... »

Caraco Pharma to merge with majority owner Sun

Tuesday, March 1, 2011 08:00 AM

Detroit-based Caraco Pharmaceutical Laboratorieshas agreed to merge with majority owner Sun Pharmaceutical Industries andSun Pharma Global, according to Crain’s Detroit Business.

More... »